Immunological characterization of the Campylobacter jejuni 72Dz/92 cjaD gene product and its fusion with B subunit of E. coli LT toxin

Acta Microbiologica Polonica

Volumn 51, Issue 4, 2002, Pages 313-326

  Wyszńska, Agnieszka ^a   Pawelec, Dariusz P ^a   Jagusztyn Krynicka, Elzbieta K ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; GANGLIOSIDE GM1; GENE PRODUCT; HYBRID PROTEIN; LT TOXIN; PROTEIN CJAD; UNCLASSIFIED DRUG;

ARTICLE; BETA CHAIN; BINDING AFFINITY; CAMPYLOBACTER JEJUNI; CELLULAR DISTRIBUTION; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC ANALYSIS; IMMUNOLOGICAL PROCEDURES; MOLECULAR CLONING; NONHUMAN; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CAMPYLOBACTER JEJUNI; CLONING, MOLECULAR; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; IMMUNITY, MUCOSAL; RABBITS; RECOMBINANT FUSION PROTEINS;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER JEJUNI; ESCHERICHIA COLI; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0036908147     PISSN: 01371320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Aspinall G.O., S. Fujimoto, A.G. McDonald, H. Pang, L.A. Kurjanczyk and J.L. Penner. 1994. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62: 2122-2125.
2. Baqar S., L.A. Applebee and A.L. Bourgeois. 1995a. Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. Infect. Immun. 63: 3731-3735.
3. Baqar S., A.L. Bourgeois, P.J. Schultheiss, R.I. Walker, D.M. Rollins, R.L. Haberberger and O.R. Pavlovskis. 1995b. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in nonhuman primates. Vaccine 13: 22-28.
4. Burnens A., U. Sticki, J. Nicolet and J. Frey. 1995. Identification and characterization of an immunogenic outer membrane protein of Campylobacter jejuni. J. Clin. Microbiol. 33: 2826-2832.
5. nd Ed., revised and expanded. Marcel Dekker, Inc. New York, Basel, Hong-Kong.
6. Chong C., M. Friberg and J.D. Clements. 1998. LT(R192G), a non toxic mutant of the heatlabile enterotoxin of Escherichia coli elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine 16: 732-740.
7. Cutriss III R. and J.O. Hassan. 1996. Nonrecombinant and recombinant avirulent Salmonella vaccines for poultry. Vet. Immunol. Immunopathol. 54: 365-372.
8. Dale J.B. and E.C. Chiang. 1995. Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J. Infect. Dis. 171: 1038-1041.
9. De Haan L., W.R. Verweij, I.K. Feil, T.H. Lijnema, W.G. Hol, E. Agsteribbe and J. Wilschut. 1996. Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infect. Immun. 64: 5413-5416.
10. Doggett T.A., E.K. Jagusztyn-Krynicka and R. Curtiss III. 1993. Immune responses to Streptococcus sobrinus surface protein antigen A expressed by recombinant Salmonella typhimurium. Infect. Immun. 61: 1859-1866.
11. nd Ed., revised and expanded. Marcel Dekker, Inc. New York, Basel, Hong-Kong.
12. Douce G., M.M. Giuliani, V. Giannelli, M.G. Pizza, R. Rappuoli and G. Dougan. 1998. Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli. Vaccine 16: 1065-1073.
13. Duim B., C.W. Ang, A. van Belkum, A. Rigter, N.W. van Leeuwen, H.P. Endtz and J.A. Wagenaar. 2000. Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barré or Miller Fisher syndrome. Appl. Environ. Microbiol. 66: 3917-3923.
14. nd Ed., revised and expanded. Marcel Dekker, Inc. New York, Basel, Hong-Kong.
15. Freytag L.C. and J.D. Clements. 1999. Bacterial toxins as mucosal adjuvants. Curr. Top. Microbiol. Immunol. 236: 215-236.
16. Galán J.E., K. Nakayama and R. Curtiss III. 1990. Cloning and characterization of the asd gene Salmonella typhimurium: Use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94: 29-35.
17. Hanna Z., C. Fregeau, G. Préfontaine and R. Brousseau. 1984. Construction of a family of universal expression plasmid vectors. Gene 30: 247-250.
18. Hayward C.M., P. O'Gaora, D.B. Young, G.E. Griffin, J. Thole, T.R. Hirst, L.R. Castello-Branco and D.J. Lewis. 1999. Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin. Vaccine 17: 1272-1281.
19. Henderson B., M. Wilson and B. Wren: 1997. Are bacterial exotoxins cytokine network regulators? Trends Microbiol. 5: 454-458.
20. Harokopakis E., G. Hajishengallis, T.E. Greenway, M.W. Russell and S.M. Michalek. 1997. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect. Immun. 65: 1445-1454.
21. Jagusztyn-Krynicka E.K., J.E. Clark-Curtiss and R. Curtiss III. 1993. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: Importance of the linker for antigenicity and biological activities of the hybrid proteins. Infect. Immun. 61: 1004-1015.
22. Khoury C.A. and R.J. Meinersmann. 1995. A genetic hybrid of the Campylobacter jejuni flatA gene with LT-B of Escherichia coli and assessment of the efficacy of the hybrid protein as an oral chicken vaccine. Avian Dis. 39: 812-820.
23. Konkel M.E., D.J. Mead and W. Cieplak Jr. 1996. Cloning, sequencing and expression of a gene from Campylobacter jejuni encoding a protein (Omp 18) with similarity to peptidoglycan-associated lipoproteins. Infect. Immun. 64: 1850-1853.
24. Lee A. and M. Chen. 1994. Successful immunization against gastric infection with Helicobacter species: Use of a cholera toxin B-subunit-whole-cell vaccine. Infect. Immun. 62: 3594-3597.
25. Lee L.H., E. Burg III, S. Baqar, A.L. Bourgeois, D.H. Burr, C.P. Ewing, T.J. Trust and P. Guerry. 1999. Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. Infect. Immun. 67: 5799-5805.
26. nd Ed., revised and expanded. Marcel Dekker, Inc. New York, Basel, Hong-Kong.
27. 1-like lipo-oligosaccharide of Campylobacterjejuni. Mol. Microbiol. 37: 501-514.
28. Newell D.G. and I. Nachamkin. 1992. Immune responses directed against Campylobacterjejuni, p. 201-206. In: I. Nachamkin, M.J. Blaser and L.S. Tompkins (eds), Campylobacter Jejuni, Current Status and Future Trends. American Society for Microbiology, Washington, D.C.
29. Pace J.L., H.A. Rossi, V.M. Esposito, S.M. Frey, K.D. Tucker and R.I. Walker. 1998. Inactivated whole-cell bacterial vaccines: Current status and novel strategies. Vaccine 16: 1563-1574.
30. Patton C.M. and I.K. Wachsmuth. 1992. Typing schemes: Are current methods useful?, p. 110-128. In: I. Nachamkin, M.J. Blaser and L.S. Tompkins (eds), Campylobacter Jejuni, Current Status and Future Trends. American Society for Microbiology, Washington, D.C.
31. Parkhill J., B.W. Wren, K. Mungall, J.M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R.M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A.V. Karlyshev, S. Moule, M.J. Pallen, C.W. Penn, M.A. Quail, M.A. Rajandream, K.M. Rutherford, A.H. van Vliet, S. Whitehead and B.G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665-668.
32. Pawelec D., E. Rożynek, J. Popowski and E.K. Jagusztyn-Krynicka. 1997. Cloning and characterization of a Campylobacter jejuni 72Dz/92 gene encoding 30 kDa immunopositive protein, component of the ABC transport system; expression of the gene in avirulent Salmonella typhimurium. FEMS Immunol. Med. Microbiol. 19: 137-150.
33. Pawelec D., A. Matracka, B. Blaszczak, G. Madajczak, M. Binek and E.K. Jagusztyn-Krynicka. 1999. Immunogenicity of an avirulent Salmonella enterica sv. Typhimurium expressing Campylobacter genes., (abstr.), p. 108, 10th Int. Workshop on Campylobacters, Helicobacters and Related Organisms, Baltimore, Maryland, USA.
34. Pei Z., C. Burucoa, B. Grignon, S. Baqar, X.Z. Huang, D.J. Kopecko, A.L. Bourgeois, J.L. Fauchere and M.J. Blaser. 1998. Mutation in peb 1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect. Immun. 66: 938-943.
35. Peterson J.W., R.A. Finkelstein, J. Cantu, D.L. Gessell and A.K. Chopra. 1999. Cholera toxin B subunit activates arachidonic acid metabolism. Infect. Immun. 67: 794-799.
36. Rice B.E., D.M. Rollins, E.T. Mallinson, L. Carr and S.W. Joseph. 1997. Campylobacter jejuni in broiler chickens: Colonization and humoral immunity following oral vaccination and experimental infection. Vaccine 15: 1922-1932.
37. Sambrook J.E., E.F. Fritsch and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY.
38. Schagger H. and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate -polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166: 368-379.
39. Schodel F., S.M. Kelly, D.L. Peterson, D.R. Milich and R. Curtiss III. 1994. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect. Immun. 62: 1669-1676.
40. nd Ed., Revised and Expanded. Marcel Dekker, Inc. New York, Basel, Hong-Kong.
41. Spratt B.G., P.J. Hedge, S. te Hessen, A. Edelman and J.K. Broome-Smith. 1986. Kanamycin-resistant vectors that are analogues of plasmid pUC8, pUC9, pEMBL8 and pEMBL9, Gene 41: 337-342.
42. Stern N.J. 1992. Reservoirs for Campylobacter jejuni and approaches for intervention in poultry, p. 49-60. In: I. Nachamkin, M.J. Blaser and L.S. Tompkins (eds), Campylobacter Jejuni, Current Status and Future Trends. American Society for Microbiology, Washington, D.C.
43. Takahashi I., H. Kiyono, R.J. Jackson, K. Fujihashi, H.F. Staats, S. Hamada, J.D. Clements, K.L. Bost and J.R. McGhee. 1996. Epitope maps of Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect. Immun. 64: 1290-1298.
44. Tauxe R.V. 1992. Epidemiology of Campylobacter Jejuni infections in the United States and other industrialized nations, p. 9-19. In: I. Nachamkin, M.J. Blaser and L.S. Tompkins (eds), Campylobacter jejuni, Current Status and Future Trends. American Society for Microbiology, Washington, D.C.
45. Taylor D.N. 1992. Campylobacter infections in developing countries., p. 20-30. In: I. Nachamkin, M.J. Blaser and L.S. Tompkins (eds), Campylobacter Jejuni, Current Status and Future Trends. American Society for Microbiology, Washington, D.C.
46. Wassenaar T.M. and D.G. Newell. I. 2000. Genotyping of Campylobacter spp. Appl. Environ. Microbiol. 66: 1-9.
47. Wu H.Y. and M.W. Russell. 1998. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine 16: 286-292.
48. Zhang X., S.M. Kelly, W. Bollen and R. Curtiss III. 1999. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains. Microb. Pathogen. 26: 121-130.